Agile Therapeutics Inc








Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise



agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at connect with us on twitter at @agilether.

Market Cap: 3.39 Million

Primary Exchange: NASDAQ


Shares Outstanding: 1.93 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 0.7588194606314413

Sector: Manufacturing

Industry: Pharmaceutical Preparation Manufacturing

Ethical Flags

Longest drawdown: 2368 trading days

From: 2015-04-16 To: 2023-04-10

Lowest Point:

Roth likes Village Farms in premarket analyst action

via: SeekingAlpha at 2019-06-13 03:36:02:000

Argenx (NASDAQ: AGRX ) initiated with Buy rating and 140 (28% upside) price target at Kepler Cheuvreux. More news on: Agile Therapeutics, Inc., Village Farms International, Inc., Savara Inc., Healthcare stocks news, Stocks on the move, , Read more … read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud